mRNA-1403, mRNA-1405 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-22 in 3mo
ESTIMATED |
READOUT
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 an
Phase 1/2 · Norovirus Acute Gastroenteritis |
ModernaTX, Inc. | mRNA-1403, mRNA-1405 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|